170460 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Hormones Insulins
SYSTEMS AND METHODS FOR OPTICALLY SENSING ANALYTE CONCENTRATIONS WITHIN MEDICAMENT DELIVERY DEVICES
#2METHODS FOR QUANTITATION OF INSULIN AND C-PEPTIDE
#3METHODS AND APPARATUS FOR MEASURING INSULIN RESISTANCE BY DETECTION OF NORMAL AND ABNORMAL INSULIN ISOMERS AND MODULATION OF INSULIN RESISTANCE TREATMENT
#4SYSTEMS, DEVICES AND METHODS FOR SENSING BIOMARKERS USING ENZYMATIC AND IMMUNOSENSING ELECTROCHEMICAL DETECTION TECHNIQUES
#5Production of Hybrid Peptides by Antigen Presenting Cells
#6Method and System for the Safety, Analysis, and Supervision of Insulin Pump Action and Other Modes of Insulin Delivery in Diabetes
#7QUANTITATION OF INSULIN BY MASS SPECTROMETRY
#8INSULIN EFFICACY EVALUATION TESTER FOR AMYLOID FIBRIL
#9METHODS OF LOADING A STREPTAVIDIN COLUMN WITH BIOTINYLATED AFFINITY AGENTS
#10BIOMARKERS FOR EARLY DETECTION OF DIABETES
#11METHODS FOR THE SIMULTANEOUS DETECTION AND QUANTIFICATION OF INSULIN, PROINSULIN, PROINSULIN METABOLIC INTERMEDIATES, C-PEPTIDE, AND C-PEPTIDE VARIANTS BY MASS SPECTROMETRY
#12PEPTIDE MODULATORS OF THE INTERACTION BETWEEN HUMAN C-PEPTIDE AND HUMAN ELASTIN RECEPTOR FOR THERAPEUTIC USE
#13METHODS OF IDENTIFYING SUBJECTS RESPONSIVE TO TREATMENT FOR AN AUTOIMMUNE DISEASE AND COMPOSITIONS FOR TREATING THE SAME
#14C PEPTIDE DETECTION BY MASS SPECTROMETRY
#15USE OF BMMF1 REP PROTEIN AS DIAGNOSTIC MARKER FOR PANCREATIC CANCER AND DIABETES MELLITUS TYPE 2
#16Treatment Of Hyperglycemia With Solute Carrier Family 39 Member 5 (SLC39A5) Inhibitors
#17Methods and Kits for Determining Insulin Resistance Treatment
#18METHODS FOR QUANTITATION OF INSULIN AND C-PEPTIDE
#19METHODS OF LOADING A STREPTAVIDIN COLUMN WITH BIOTINYLATED AFFINITY AGENTS
#20MULTIPLEXED NANO-BIOSENSOR SYSTEM FOR EARLY DETECTION OF DIABETES
#21HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE
#22Precision Medicine Approach to Targeting Neurodegeneration
#23PECVD coated pharmaceutical packaging
#24C peptide detection by mass spectrometry
#25INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES MELLITUS
#26METHODS FOR QUANTITATION OF INSULIN LEVELS BY MASS SPECTROMETRY
#27CORRECTING PROTEIN MISFOLDING IN DIABETES
#28C peptide detection by mass spectrometry
#29METHOD OF USING FOLLISTATIN IN TYPE 2 DIABETES RISK PREDICTION
#30PECVD coated pharmaceutical packaging
#31Biosensor array for the detection of analytes
#32SYSTEMS, DEVICES AND METHODS FOR SENSING BIOMARKERS USING ENZYMATIC AND IMMUNOSENSING ELECTROCHEMICAL DETECTION TECHNIQUES
#33COMPOSITIONS AND METHODS FOR IDENTIFYING METABOLICALLY ACTIVE AGENTS
#34METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES
#35Methods for quantitation of insulin and C-peptide
#36CELL-BASED BIOIDENTITY TEST FOR INSULIN
#37QUANTITATION OF INSULIN BY MASS SPECTROMETRY
#38IMMUNOASSAY FOR MEASURING C-PEPTIDE
#39Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes
#40LATERAL FLOW ASSAY SYSTEMS AND METHODS FOR THE QUANTIFICATION OF A BIOLOGICAL SAMPLE
#41Aluminum metasurfaces for highly sensitive and enhanced detection of analytes for smartphone diagnostics and methods for making and using the same
#42Systems and methods for sample use maximization
#43USE OF QUINALDINE RED AND DERIVATIVES THEREOF IN PREPARATION OF KIT FOR DETECTING AMYLOID FIBRILS
#44Compositions for and methods of diagnosing, prognosing, and treating diabetes
#45C peptide detection by mass spectrometry
#46Peptide mapping method for sequence identification of insulin and insulin analogues
#47Lipid bilayer membrane mimic
#48DETECTION OF INSULIN IN SALIVA AND METHODS OF USE THEREOF
#49MARKERS FOR DIAGNOSIS AND PROGNOSTIC PREDICTION OF NPC AND APPLICATION THEREOF
#50Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors
#51Quantitation of insulin by mass spectrometry of insulin A chain
#52BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS
#53Graphene-based nanosensor for identifying target analytes
#54Methods for Producing Enteroendocrine Cells That Make and Secrete Insulin
#55Compositions and methods for identifying metabolically active agents
#56Bioassay for insulin formulations
#57Methods for quantitation of insulin levels by mass spectrometry
#58C peptide detection by mass spectrometry
#59BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS
#60Personalized healthcare P4 drug monitoring system and method
#61BIO-ANALYTICAL METHOD FOR INSULIN ANALOGUES
#62C peptide detection by mass spectrometry
#63Biosensor array for the detection of analytes
#64STEM CELLS FOR MODELING TYPE 2 DIABETES
#65Methods for quantitation of insulin and C-peptide
#66Aptamer against insulin receptor and pharmaceutical compostion containing the same
#67GRAPHENE-BASED NANOSENSOR FOR IDENTIFYING TARGET ANALYTES
#68Protein corona phase molecular recognition
#69MICROWELL COLLECTION OF PARTICLES
#70Method for detecting neutralizing antibodies against recombinant human insulin in human serum
#71Solid Phase Assay for Detecting Biomarkers for Cardiodiabetes
#72Glucose sensors and methods of use thereof
#73C peptide detection by mass spectrometry
#74COMPOSITIONS AND METHODS FOR IDENTIFYING METABOLICALLY ACTIVE AGENTS
#75SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT
#76Compositions and methods for diagnosing, monitoring, and treating an autoimmune disease
#77Biomarkers
#78METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES
#79BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS
#80DEVICES FOR DETECTION OF ANTIBODIES AGAINST THERAPEUTIC DRUGS
#81Method of screening a drug such as insulin secretagogue
#82GLUT-1 AS A RECEPTOR FOR HTLV ENVELOPES AND ITS USES
#83Device and associated methods for performing luminescence and fluorescence measurements of a sample
#84Device and associated methods for performing luminescence and fluorescence measurements of a sample
#85Systems and methods for sample use maximization
#86Personalized Glucose and Insulin Monitoring System
#87METHOD OF EXTRACTING ORGAN METABOLIC FUNCTIONS USING ORAL GLUCOSE TOLERANCE TESTS AND DEVICE THEREFOR
#88METHOD FOR SCREENING DRUG-SACCHARIDE CONJUGATES
#89Glucose sensors and methods of use thereof
#90Automated immunoanalyzer system for performing diagnostic assays for allergies and autoimmune diseases
#91Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#92Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#93Methods for producing hormone secreting cells in a subject
#94CHALCONE-UREA DERIVATIVES AS INSULIN SENSORS
#95Assays using a multi-divot platform and multi-source, multi-cell type clusters
#96Methods for producing enteroendocrine cells that make and secrete insulin
#97Method for treating or preventing a pancreatic dysfunction
#98Use of P2X Purinergic Receptor Agonists to Enhance Insulin Secretion In Pancreatic Beta Cells
#99Method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes
#100Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay
#101Systems and methods for sample use maximization
#102Biomarkers for Cardiodiabetes
#103Methods for quantitation of insulin levels by mass spectrometry
#104INSULIN ASSAY
#105Methods of identifying subjects responsive to treatment for type 1 diabetes and compositions for treating the same
#106SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT
#107Stem cells for modeling type 2 diabetes
#108Container
#109Systems and methods for sample use maximization
#110Method of screening a drug such as insulin secretagogue
#111Systems and methods for sample use maximization
#112Method for predicting the risk of getting cancer or diagnosing cancer in a subject
#113C peptide detection by mass spectrometry
#114Insulin derivatives for diabetes treatment
#115Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes
#116Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases
#117Assays using a multi-divot platform and multi-source, multi-cell type clusters
#118Method of treating vascular insulin resistance in a normoglycemic subject based on biomarkers
#119Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#120Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#121Systems and methods for sample use maximization
#122Electrode and use thereof
#123Device and associated methods for performing luminescence and fluorescence measurements of a sample
#124Device and associated methods for performing luminescence and fluorescence measurements of a sample
#125GLUT-1 as a receptor for HTLV envelopes and its uses
#126Method for the Selection of Serum Biomarkers of Epigenetic Alterations, Particularly of Global Hypomethylation and Their Uses
#127Water-soluble AIE luminogens for monitoring and retardation of fibrillation of amyloid proteins
#128Hepatic insulin sensitizing substance and test meal for insulin sensitization
#129FUNCTIONAL CELL SURFACE DISPLAY OF LIGANDS FOR THE INSULIN AND/OR INSULIN GROWTH FACTOR 1 RECEPTOR AND APPLICATIONS THEREOF
#130MODULATION OF GHRELIN LEVELS AND GHRELIN/UNACYLATED GHRELIN RATIO USING UNACYLATED GHRELIN
#131Automated immunoanalyzer system for performing diagnostic assays for allergies and autoimmune diseases
#132Maintaining multiple defined physiological zones using model predictive control
#133Methods for producing enteroendocrine cells that make and secrete insulin
#134Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin
#135Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes
#136Use of P2X Purinergic Receptor Agonists to Enhance Insulin Secretion in Pancreatic Beta Cells
#137MICRORNA REGULATING THE INSULIN SIGNALING PATHWAY, AND METHOD FOR SCREENING MATERIAL FOR CONTROLLING THE ACTION OF A TARGET THEREOF
#138HUMAN INSULIN ASSAY AND ASSAY REAGENT
#139SYSTEMS AND METHODS FOR SAMPLE USE MAXIMIZATION
#140Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay
#141Multiplexed assay methods
#142Autism-associated biomarkers and uses thereof
#143BIOMARKERS OF PROSTATE CANCER AND PREDICTING MORTALITY
#144Water-soluble AIE luminogen for monitoring and retardation of amyloid fibrillation of insulin
#145Quantitation of insulin by tandem mass spectrometry of insulin B chain
#146METHOD OF SCREENING FOR INSULIN SECRETION-POTENTIATING AGENTS
#147Treatment of muscle disease characterized by insulin resistance
#1485-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related Disorders
#149BIOMARKERS AND ASSAYS FOR DIABETES
#150Method for treating or preventing a pancreatic dysfunction
#151Nucleic acid ligand complexes
#152Insulin assay
#153Biomarkers for insulin sensitizer drug response
#154Biomarkers
#155Potentiators of insulin secretion
#156RISK ANALYSIS IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROME
#157METHODS FOR MEASURING THE INSULIN RECEPTOR ALPHA SUBUNIT
#158Marks as modifiers of the p53 pathway and methods of use
#159Method of screening a drug such as insulin secretagogue
#160Biomarkers for Adipose Tissue Activity
#161Multiplexed assay methods
#162Biomarkers for cardiodiabetes
#163Method of treating a subject according to biomarkers for insulin resistance
#164Glycated Insulin as a Biomarker for Diagnosis and Monitoring of Diabetes
#165Method for Evaluating Obesity Controller
#166Nanobodies and Polypeptides Against EGFR and IGF-IR
#167Increasing glucose transport and insulin-stimulated glucose uptake
#168Method and index for diagnosing insulin resistance
#169Method for Determining Insulin Sensitivity and Glucose Absorption
#170FGF21 upregulates expression of GLUT-1 in a βklotho-dependent manner
#171MARKs as Modifiers of the p53 Pathway and Methods of Use
#172Method For Measuring Proinsulin And C-Peptide And A Kit Therefor
#173Method for evaluating insulin resistance
#174Methods of screening for TRPM4 modulators of insulin secretion
#175Methods and compositions for the diagnosis of treatment of type 2 diabetes
#176Methods for measuring the insulin receptor α subunit
#177Treatment of Alzheimer's Disease
#178Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP
#179Assessing insulin resistance using biomarkers
#180Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
#181Mechanism for identifying drugs for the treatment of type II diabetes
#182β2-adrenergic receptor agonists
#183LIMKs as modifiers of p53 pathway and methods of use
#184Glucose-transport related genes, polypeptides, and methods of use thereof
#185Multiplexed assay methods
#186Glycated insulin as a biomarker for diagnosis and monitoring of diabetes
#187Tenascin-C nucleic acid ligands
#188Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
#189Minrs as modifiers of insulin receptor signaling and methods of use
#190Antibodies to insulin/IGF/relaxin family polypeptides
#191GLUT1 transporters expressed in cancer cells
#192β2-adrenergic receptor agonists
#193Methods of identifying insulin response modulators and uses therefor
#194Nucleic acid ligand complexes
#195Specific-C-peptide assay method
#196Truncation SELEX method
#197Potentiators of insulin secretion
#198Method for differentiating stem cells into insulin-producing cells
#199High affinity RNA ligands of basic fibroblast growth factor
#200C-peptide specific assay procedure
#201Lactate dehydrogenase as a novel target and reagent for diabetes therapy
#202Cell-free assay for insulin signaling
#203Use of insulin response modulators in the treatment of diabetes and insulin resistance